Bryan R Spencer
Overview
Explore the profile of Bryan R Spencer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
63
Citations
599
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Roubinian N, Greene J, Spencer B, Bravo M, Bruhn R, Saa P, et al.
Transfusion
. 2025 Feb;
PMID: 40012124
Background: Despite data supporting the safety of SARS-CoV-2 vaccination, concerns regarding the receipt of blood products from donors previously infected or vaccinated against SARS-CoV-2 persist. We assessed whether transfusions of...
2.
Di Germanio C, Deng X, Balasko B, Simmons G, Martinelli R, Grebe E, et al.
Transfusion
. 2024 Oct;
64(11):2063-2074.
PMID: 39373096
Background: COVID-19 convalescent plasma (CCP) remains a treatment option for immunocompromised patients; however, the current FDA qualification threshold of ≥200 BAU/mL of spike antibody appears to be relatively low. We...
3.
Stanley J, Busch M, Erikstrup C, Galel S, Holmberg J, Lewin A, et al.
Vox Sang
. 2024 Jul;
119(10):1122-1125.
PMID: 39054253
Background And Objectives: Data provided from blood donors have contributed to the understanding of public health epidemiology and policy decisions. A recent example was during the severe acute respiratory syndrome-related...
4.
Avelino-Silva V, Bruhn R, Zurita K, Deng X, Yu E, Grebe E, et al.
Transfusion
. 2024 Jul;
64(9):1719-1731.
PMID: 38984497
Background: Long COVID is a common condition lacking consensus definition; determinants remain incompletely understood. Characterizing immune profiles associated with long COVID could support the development of preventive and therapeutic strategies....
5.
Grebe E, Stone M, Spencer B, Akinseye A, Wright D, Di Germanio C, et al.
Emerg Infect Dis
. 2024 Jul;
30(8):1621-1630.
PMID: 38981189
Nucleocapsid antibody assays can be used to estimate SARS-CoV-2 infection prevalence in regions implementing spike-based COVID-19 vaccines. However, poor sensitivity of nucleocapsid antibody assays in detecting infection after vaccination has...
6.
Shi D, Rinsky J, McDonald E, Shah M, Groenewold M, de Perio M, et al.
Am J Ind Med
. 2024 Jun;
67(8):764-771.
PMID: 38856006
Objective: To describe coronavirus disease 2019 (COVID-19) mitigation measures in workplaces of employed US blood donors by industry and work arrangement. Methods: During May-December 2021, blood donors responded to a...
7.
Shah M, Spencer B, James-Gist J, Haynes J, Feldstein L, Stramer S, et al.
JAMA Netw Open
. 2024 Apr;
7(4):e245611.
PMID: 38587842
Importance: Long-term symptoms, lasting more than 4 consecutive weeks after acute COVID-19 disease, are an important consequence of SARS-CoV-2 infection. Many prior studies have lacked a non-SARS-CoV-2-infected control population to...
8.
Stone M, Spencer B, Warden D, Fink R, Saa P, Leddy J, et al.
J Infect Dis
. 2024 Mar;
230(2):357-362.
PMID: 38470857
Serial blood and mucosal samples were characterized for 102 participants enrolled a median of 7.0 days after coronavirus disease 2019 diagnosis. Mucosal RNA was detectable for a median of 31.5...
9.
Wheeler A, Snyder E, Refaai M, Cohn C, Poisson J, Fontaine M, et al.
Blood Adv
. 2024 Mar;
8(9):2290-2299.
PMID: 38447116
Patients treated with antineoplastic therapy often develop thrombocytopenia requiring platelet transfusion, which has potential to exacerbate pulmonary injury. This study tested the hypothesis that amotosalen-UVA pathogen-reduced platelet components (PRPCs) do...
10.
Roubinian N, Greene J, Liu V, Lee C, Mark D, Vinson D, et al.
Transfusion
. 2023 Dec;
64(1):53-67.
PMID: 38054619
Background: The safety of transfusion of SARS-CoV-2 antibodies in high plasma volume blood components to recipients without COVID-19 is not established. We assessed whether transfusion of plasma or platelet products...